FDA inspection
Glaxo Operations UK Limited: FDA inspection ending Dec 6, 2024
FDA inspection 1267917 · Voluntary Action Indicated (VAI) · Ware
Key facts
| Inspection ID | 1267917 |
|---|---|
| Firm | Glaxo Operations UK Limited |
| FEI number | 3003262904 |
| Address | Priory Street |
| City | Ware |
| Country | United Kingdom |
| Fiscal year | 2025 |
| Inspection end date | Dec 6, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data